Business Context and Reporting Period
This Form 8-K Current Report was filed by Renovaro Biosciences Inc. (formerly Enochian Biosciences Inc.) on August 1, 2023. The filing reports a corporate name change effective immediately as of 5:04 P.M. Eastern Time on August 1, 2023, following the filing of a Certificate of Amendment of Certificate of Incorporation with the State of Delaware.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current event disclosure regarding a corporate name change and does not contain financial statements or performance metrics.
Material Changes
- Corporate Name: Changed from Enochian Biosciences Inc. to Renovaro Biosciences Inc.
- Legal Status: The amendment was filed with the Delaware Secretary of State and is effective immediately.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to the procedural announcement of the name change.
Investor Verification Checklist
- Verify the new trading symbol and ticker status on The Nasdaq Stock Market LLC following the name change.
- Confirm the effective date of the name change (August 1, 2023) for historical data tracking.
- Review the attached Exhibit 3.1 (Certificate of Amendment) for any additional bylaw changes not summarized in the text.